Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.

Breast Neoplasms / therapy Cost-Benefit Analysis Exercise Therapy / economics Female Follow-Up Studies Humans Markov Chains Neoplasm Recurrence, Local Quality of Life Quality-Adjusted Life Years
breast cancer cost-effectiveness analysis cost-utility analysis exercise

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
19 11 2020
Historique:
received: 09 11 2020
revised: 16 11 2020
accepted: 17 11 2020
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 2 2 2021
Statut: epublish

Résumé

Studies show conflicting results on whether exercise interventions to improve outcomes for women with breast cancer are cost-effective. We modelled the long-term cost-effectiveness of the

Identifiants

DOI: 10.3390/ijerph17228608 PMID: 33228174 PMC: PMC7699530
pubmed: 33228174
pii: ijerph17228608
doi: 10.3390/ijerph17228608
pmc: PMC7699530
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Breast Cancer Foundation
ID : n/a
Pays : International

Références

PLoS One. 2015 Apr 10;10(4):e0120832
pubmed: 25861031
J Sci Med Sport. 2019 Nov;22(11):1175-1199
pubmed: 31277921
J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):382-98
pubmed: 24690072
Breast Cancer Res Treat. 2013 Jan;137(1):175-86
pubmed: 23139058
JNCI Cancer Spectr. 2019 Oct 17;4(1):pkz080
pubmed: 32337494
Breast Cancer Res Treat. 2018 Jan;167(2):505-514
pubmed: 29063309
Med J Aust. 2018 Aug 20;209(4):184-187
pubmed: 29719196
Med Sci Sports Exerc. 2019 Nov;51(11):2391-2402
pubmed: 31626056
Breast Cancer Res Treat. 2019 Jul;176(1):37-52
pubmed: 30997624
Med Oncol. 2011 Sep;28(3):753-65
pubmed: 20411366
J Clin Oncol. 2006 May 1;24(13):2028-37
pubmed: 16648502
Br J Cancer. 2012 Mar 13;106(6):1045-52
pubmed: 22415293
J Clin Oncol. 2009 May 20;27(15):2466-73
pubmed: 19349544
BMJ Open. 2017 Mar 6;7(3):e012187
pubmed: 28264824
Support Care Cancer. 2020 Jun;28(6):2829-2842
pubmed: 31729566
PLoS One. 2016 Dec 12;11(12):e0167521
pubmed: 27942032
Lancet Oncol. 2018 Sep;19(9):e432
pubmed: 30191842
Breast. 2019 Apr;44:144-152
pubmed: 30780085
Oncologist. 2012;17(12):1581-93
pubmed: 22982580
BMC Palliat Care. 2017 Jun 21;17(1):1
pubmed: 28637450
Psychooncology. 2017 May;26(5):649-655
pubmed: 27338125
Lancet Glob Health. 2020 Aug;8(8):e1027-e1037
pubmed: 32710860
Pharmacoeconomics. 2007;25(1):3-6
pubmed: 17192114
BMC Public Health. 2014;14 Suppl 3:S8
pubmed: 25437351
Adv Exp Med Biol. 2017;1000:103-129
pubmed: 29098619
Ann Behav Med. 2012 Apr;43(2):229-38
pubmed: 22109352
Acta Oncol. 2015 May;54(5):635-54
pubmed: 25752971
Breast Cancer Res Treat. 2010 Nov;124(1):163-75
pubmed: 20734132
Contemp Clin Trials. 2011 Jul;32(4):577-85
pubmed: 21463707
Eur J Health Econ. 2018 Jul;19(6):893-904
pubmed: 29086085
Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):549-559
pubmed: 27574879
Pharmacoeconomics. 2006;24(4):355-71
pubmed: 16605282
Cureus. 2016 Dec 9;8(12):e924
pubmed: 28090417
Value Health. 2013 Mar-Apr;16(2):e1-5
pubmed: 23538200
CA Cancer J Clin. 2018 Jan;68(1):64-89
pubmed: 29165798
Ann Oncol. 2014 Jul;25(7):1293-1311
pubmed: 24644304
Aust N Z J Public Health. 2019 Oct;43(5):484-495
pubmed: 31390112

Auteurs

Louisa G Gordon (LG)

Population Health Department, QIMR Berghofer Medical Research Institute, Locked Bag 2000, Royal Brisbane Hospital, Brisbane, Qld 4029, Australia.
School of Nursing, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, Qld 4059, Australia.
Faculty of Medicine, School of Public Health, The University of Queensland, Herston, Brisbane, Qld 4006, Australia.
ORCID: 0000-0002-3159-4249

Elizabeth G Eakin (EG)

Faculty of Medicine, School of Public Health, The University of Queensland, Herston, Brisbane, Qld 4006, Australia.

Rosalind R Spence (RR)

Menzies Health Institute Qld, Griffith University, Nathan, Brisbane, Qld 4111, Australia.

Christopher Pyke (C)

Mater Public and Private Hospital, South Brisbane, Qld 4101, Australia.

John Bashford (J)

The Wesley Hospital, Auchenflower, Brisbane, Qld 4066, Australia.

Christobel Saunders (C)

Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA 6009, Australia.

Sandra C Hayes (SC)

Menzies Health Institute Qld, Griffith University, Nathan, Brisbane, Qld 4111, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Thérapeutique › Techniques de physiothérapie › Traitement par les exercices physiques › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études de suivi › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Processus stochastiques › Chaines de Markov › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Récidive tumorale locale › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Cost-Effectiveness Analysis from a Randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Espérance de vie › Années de vie ajustées sur la qualité › Cost-Effectiveness Analysis from a Randomized...